NVCR
$15.71+5.51%
NovoCure LimitedStock · HealthcareRussell 2000 · 0.05% of IWMNasdaq Composite · 0.008% of ONEQUS Stock Market · 0.002% of VTIRussell 3000 · 0.002% of IWV
NovoCure Limited total returns by year (including dividends)
As of market close, Oct 20, 2026
NovoCure Limited total returns by year (2016–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $12.93 | $15.71 | 0.0% | +21.5% | |
| 2025 | $29.80 | $12.93 | 0.0% | -56.6% | |
| 2024 | $14.93 | $29.80 | 0.0% | +99.6% | |
| 2023 | $73.35 | $14.93 | 0.0% | -79.6% | |
| 2022 | $75.08 | $73.35 | 0.0% | -2.3% | |
| 2021 | $173.04 | $75.08 | 0.0% | -56.6% | |
| 2020 | $84.27 | $173.04 | 0.0% | +105.3% | |
| 2019 | $33.48 | $84.27 | 0.0% | +151.7% | |
| 2018 | $20.20 | $33.48 | 0.0% | +65.7% | |
| 2017 | $7.85 | $20.20 | 0.0% | +157.3% | |
| 2016 | $22.36 | $7.85 | 0.0% | -64.9% |
- Annualized
- -3.2%
- 2016–2026
- Average year
- +32.0%
- 10 full years
- Best year
- +157.3%
- 2017
- Worst year
- -79.6%
- 2023
- Positive years
- 5/10
- 50% up
Annualized (CAGR)
-3.2%
2016–2026
Average year
+32.0%
10 full years
Best year
+157.3%
2017
Worst year
-79.6%
2023
Positive years
5/10
50% up
Total return by period#
Annual
-150%-100%-50%0%50%100%150%
2016-65%'16
2017+157%'17
2018+66%'18
2019+152%'19
2020+105%'20
2021-57%'21
2022-2.3%'22
2023-80%'23
2024+100%'24
2025-57%'25
2026+22%'26
Methodology#
Total returns, dividends reinvested, measured on NVCR. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is NovoCure Limited's average annual return?
- Since 2016, NovoCure Limited (NVCR) has returned about -3.2% a year (the compound annual growth rate) and an average calendar-year return of 32.0%.
- What were NovoCure Limited's best and worst years?
- Over 2016–2026, the best year was 2017 (+157.3%) and the worst was 2023 (-79.6%).
- How often is NovoCure Limited up in a year?
- 5 of the 10 full years since 2016 were positive — about 50% of the time.
More on NovoCure Limited
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100